Kodiak Sciences Inc stock closed at $32.35 on September 25, down 2.6%. The daily chart remains corrective. However, positive wet AMD trial data for Zenkuda was disclosed on September 28. Alongside Cantor Fitzgerald’s Overweight reiteration, this clinical catalyst is not yet priced into the technical snapshot below.

Key takeaways

• KOD closed at $32.35 on September 25, down 2.6% from $33.22.
• Daily RSI14 at 37.85 reflects bearish momentum without being technically oversold.
• The daily MACD histogram turned marginally positive at 0.08, signaling decelerating selling pressure.
• On September 28, Zenkuda met its primary endpoint in a wet AMD trial; Cantor Fitzgerald reiterated…